ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 92 filers reported holding ARATANA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $933,000 | -23.9% | 129,892 | -0.8% | 0.00% | -50.0% |
| Q3 2016 | $1,226,000 | +55.2% | 130,943 | +4.7% | 0.00% | +100.0% |
| Q2 2016 | $790,000 | +32.6% | 125,058 | +15.9% | 0.00% | 0.0% |
| Q1 2016 | $596,000 | +0.7% | 107,901 | +1.7% | 0.00% | 0.0% |
| Q4 2015 | $592,000 | -33.3% | 106,058 | +1.0% | 0.00% | 0.0% |
| Q3 2015 | $888,000 | -45.0% | 104,997 | -1.8% | 0.00% | -50.0% |
| Q2 2015 | $1,616,000 | +20.9% | 106,880 | +28.0% | 0.00% | 0.0% |
| Q1 2015 | $1,337,000 | -8.7% | 83,491 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $1,465,000 | +78.2% | 82,225 | +0.4% | 0.00% | +100.0% |
| Q3 2014 | $822,000 | -24.5% | 81,899 | +17.4% | 0.00% | 0.0% |
| Q2 2014 | $1,089,000 | +157.4% | 69,782 | +206.0% | 0.00% | 0.0% |
| Q1 2014 | $423,000 | +17.5% | 22,803 | +21.0% | 0.00% | 0.0% |
| Q4 2013 | $360,000 | +50.0% | 18,851 | +28.1% | 0.00% | – |
| Q3 2013 | $240,000 | – | 14,714 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $1,219,000 | 11.21% |
| Broadfin Capital, LLC | 3,428,865 | $19,133,000 | 1.18% |
| MPM ASSET MANAGEMENT LLC | 1,117,875 | $6,238,000 | 1.11% |
| AlpInvest Partners B.V. | 100,001 | $558,000 | 0.93% |
| First Light Asset Management, LLC | 395,043 | $2,204,000 | 0.92% |
| Westend Capital Management, LLC | 89,780 | $501,000 | 0.69% |
| Grandeur Peak Global Advisors, LLC | 460,675 | $2,571,000 | 0.53% |
| AWM Investment Company, Inc. | 467,507 | $2,609,000 | 0.51% |
| HAMILTON LANE ADVISORS LLC | 111,705 | $623,000 | 0.27% |
| Sio Capital Management, LLC | 97,376 | $543,000 | 0.24% |